• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隐球菌蛋白酶与 SARS-CoV-2 刺突 (S) 蛋白的激活。

Cryptococcal Protease(s) and the Activation of SARS-CoV-2 Spike (S) Protein.

机构信息

Department of Microbiology and Biochemistry, University of the Free State, 205 Nelson Mandela Drive, Park West, Bloemfontein 9301, South Africa.

出版信息

Cells. 2022 Jan 27;11(3):437. doi: 10.3390/cells11030437.

DOI:10.3390/cells11030437
PMID:35159253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8834071/
Abstract

In this contribution, we report on the possibility that cryptococcal protease(s) could activate the SARS-CoV-2 spike (S) protein. The S protein is documented to have a unique four-amino-acid sequence (underlined, SPRRAR↓S) at the interface between the S1 and S2 sites, that serves as a cleavage site for the human protease, furin. We compared the biochemical efficiency of cryptococcal protease(s) and furin to mediate the proteolytic cleavage of the S1/S2 site in a fluorogenic peptide. We show that cryptococcal protease(s) processes this site in a manner comparable to the efficiency of furin ( > 0.581). We conclude the paper by discussing the impact of these findings in the context of a SARS-CoV-2 disease manifesting while there is an underlying cryptococcal infection.

摘要

在本研究中,我们提出隐球菌蛋白酶可能会激活新冠病毒刺突(S)蛋白这一假设。有文献报道,新冠病毒 S 蛋白的 S1 和 S2 结构域连接处存在独特的四氨基酸序列(下划线,SPRRA↓S),是人类蛋白酶弗林(furin)的酶切位点。我们比较了隐球菌蛋白酶和弗林酶对荧光肽 S1/S2 位点的酶切效率。实验结果显示,隐球菌蛋白酶对该位点的酶切效率与弗林酶相当(>0.581)。最后,我们讨论了在新冠病毒感染的同时存在隐球菌感染的情况下,这些发现的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/745b/8834071/aa97c9dd9993/cells-11-00437-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/745b/8834071/f802fbda079a/cells-11-00437-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/745b/8834071/aa97c9dd9993/cells-11-00437-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/745b/8834071/f802fbda079a/cells-11-00437-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/745b/8834071/aa97c9dd9993/cells-11-00437-g002.jpg

相似文献

1
Cryptococcal Protease(s) and the Activation of SARS-CoV-2 Spike (S) Protein.隐球菌蛋白酶与 SARS-CoV-2 刺突 (S) 蛋白的激活。
Cells. 2022 Jan 27;11(3):437. doi: 10.3390/cells11030437.
2
Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein.对人类蛋白酶对 SARS-CoV-2 刺突糖蛋白进行蛋白水解切割的能力进行全基因组生物信息学分析。
Microbiol Spectr. 2024 Feb 6;12(2):e0353023. doi: 10.1128/spectrum.03530-23. Epub 2024 Jan 8.
3
Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin.SARS-CoV-2 刺突蛋白在 S1/S2 边界处的蛋白水解激活:除弗林蛋白酶以外的蛋白酶的潜在作用。
ACS Infect Dis. 2021 Feb 12;7(2):264-272. doi: 10.1021/acsinfecdis.0c00701. Epub 2021 Jan 12.
4
SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.SARS-CoV-2 刺突蛋白的弗林蛋白酶裂解位点和 S2'碱性残基以宿主细胞依赖的方式调节进入过程。
J Virol. 2022 Jul 13;96(13):e0047422. doi: 10.1128/jvi.00474-22. Epub 2022 Jun 9.
5
Cryptococcal proteases exhibit the potential to activate the latent SARS-CoV-2 spike protein.隐球菌蛋白酶具有激活潜伏的 SARS-CoV-2 刺突蛋白的潜力。
J Infect Public Health. 2024 Feb;17(2):263-270. doi: 10.1016/j.jiph.2023.12.008. Epub 2023 Dec 14.
6
A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.针对弗林蛋白酶的可行替代策略可破坏 SARS-CoV-2 感染周期。
Microbiol Spectr. 2022 Feb 23;10(1):e0236421. doi: 10.1128/spectrum.02364-21. Epub 2022 Feb 9.
7
Proteolytic activation of SARS-CoV-2 spike protein.SARS-CoV-2 刺突蛋白的蛋白水解激活。
Microbiol Immunol. 2022 Jan;66(1):15-23. doi: 10.1111/1348-0421.12945. Epub 2021 Oct 12.
8
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.SARS-CoV-2 刺突蛋白中的弗林裂解位点是在雪貂中传播所必需的。
Nat Microbiol. 2021 Jul;6(7):899-909. doi: 10.1038/s41564-021-00908-w. Epub 2021 Apr 27.
9
The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)转录组及人原代气道上皮细胞中S基因弗林蛋白酶切割位点的动态变化
mBio. 2021 May 11;12(3):e01006-21. doi: 10.1128/mBio.01006-21.
10
The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV.刺突蛋白 S1/S2 位点的序列使 SARS-CoV-2 能够被弗林蛋白酶切割和磷酸化调节,但 SARS-CoV-1 或 MERS-CoV 则不能。
Sci Rep. 2020 Oct 9;10(1):16944. doi: 10.1038/s41598-020-74101-0.

引用本文的文献

1
Aspergillus fumigatus secretes a protease(s) that displays in silico binding affinity towards the SARS-CoV-2 spike protein and mediates SARS-CoV-2 pseudovirion entry into HEK-293T cells.烟曲霉分泌一种蛋白酶,该酶在计算机模拟中显示出对 SARS-CoV-2 刺突蛋白的结合亲和力,并介导 SARS-CoV-2 假病毒进入 HEK-293T 细胞。
Virol J. 2024 Mar 6;21(1):58. doi: 10.1186/s12985-024-02331-z.
2
Evaluation of SARS-CoV-2-Positive Patients with Suspected Reinfection.评估疑似再感染 SARS-CoV-2 阳性患者。
Viruses. 2023 Nov 7;15(11):2222. doi: 10.3390/v15112222.
3
Invasive cryptococcal disease in COVID-19: systematic review of the literature and analysis.

本文引用的文献

1
COVID-19-associated Pulmonary Cryptococcosis: A Rare Case Presentation.新型冠状病毒肺炎相关肺隐球菌病:1例罕见病例报告
Indian J Crit Care Med. 2022 Jan;26(1):129-132. doi: 10.5005/jp-journals-10071-24084.
2
The Possible Role of Microbial Proteases in Facilitating SARS-CoV-2 Brain Invasion.微生物蛋白酶在促进新冠病毒脑侵袭中的可能作用
Biology (Basel). 2021 Sep 27;10(10):966. doi: 10.3390/biology10100966.
3
Airborne transmission of respiratory viruses.呼吸道病毒的空气传播。
新型冠状病毒肺炎中的侵袭性隐球菌病:文献系统综述与分析
Infez Med. 2023 Mar 1;31(1):6-12. doi: 10.53854/liim-3101-2. eCollection 2022.
4
More than Just Protein Degradation: The Regulatory Roles and Moonlighting Functions of Extracellular Proteases Produced by Fungi Pathogenic for Humans.不止于蛋白质降解:人类致病真菌产生的细胞外蛋白酶的调节作用及兼职功能
J Fungi (Basel). 2023 Jan 15;9(1):121. doi: 10.3390/jof9010121.
5
Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective.血管紧张素转化酶 2(ACE2)与严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)刺突受体结合域(RBD)的相互作用:结构视角。
Mol Biol Rep. 2023 Mar;50(3):2713-2721. doi: 10.1007/s11033-022-08193-4. Epub 2022 Dec 23.
Science. 2021 Aug 27;373(6558). doi: 10.1126/science.abd9149.
4
Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19.COVID-19 中 SARS-CoV-2 对呼吸道上皮细胞的反应。
Thorax. 2022 Feb;77(2):203-209. doi: 10.1136/thoraxjnl-2021-217561. Epub 2021 Aug 17.
5
Meningoencephalitis in an Immunocompetent Patient after COVID-19 Infection.新冠病毒感染后免疫功能正常患者发生的脑膜脑炎
Case Rep Infect Dis. 2021 Jun 4;2021:5597473. doi: 10.1155/2021/5597473. eCollection 2021.
6
Re-emerging Aspartic Protease Targets: Examining Major Aspartyl Peptidase 1 as a Target for Antifungal Drug Discovery.重新出现的天冬氨酸蛋白酶靶点:研究主要天冬氨酸肽酶 1 作为抗真菌药物发现的靶点。
J Med Chem. 2021 May 27;64(10):6706-6719. doi: 10.1021/acs.jmedchem.0c02177. Epub 2021 May 18.
7
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2.严重急性呼吸综合征冠状病毒2刺突蛋白通过下调血管紧张素转换酶2损害内皮功能。
Circ Res. 2021 Apr 30;128(9):1323-1326. doi: 10.1161/CIRCRESAHA.121.318902. Epub 2021 Mar 31.
8
SARS-CoV-2 respiratory co-infections: Incidence of viral and bacterial co-pathogens.SARS-CoV-2 呼吸道合并感染:病毒和细菌合并病原体的发生率。
Int J Infect Dis. 2021 Apr;105:617-620. doi: 10.1016/j.ijid.2021.02.087. Epub 2021 Feb 25.
9
Cryptococcemia in a patient with COVID-19: A case report.一名新冠肺炎患者的隐球菌血症:病例报告
Clin Case Rep. 2020 Dec 19;9(2):853-855. doi: 10.1002/ccr3.3668. eCollection 2021 Feb.
10
Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19.将严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白酶作为治疗2019冠状病毒病(COVID-19)的治疗策略所面临的挑战。
ACS Infect Dis. 2021 Jun 11;7(6):1457-1468. doi: 10.1021/acsinfecdis.0c00815. Epub 2021 Feb 11.